Utilization of Women’s Preventive Health Services During the COVID-19 Pandemic
Authors:
Open Access
- 2 July 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 2 (7) , e211408
Abstract
The use of recommended preventive health services is an important driver of women’s health outcomes and is associated with decreased rates of breast and cervical cancer mortality, lower rates of unwanted pregnancy and abortion, and appropriate treatment of sexually transmitted infections (STIs).1 Women’s utilization of preventive health services was made more accessible and affordable for women by the implementation of the Affordable Care Act (ACA), which expanded insurance coverage, prevented gender-based premium pricing, and mandated that commercial health plans cover effective preventive services with no out-of-pocket costs to patients. These policies have been associated with improvement in women’s utilization of preventive health services in recent years.2,3Keywords
This publication has 16 references indexed in Scilit:
- Screening for HIV InfectionJAMA, 2019
- Women's Affordability, Access, and Preventive Care After the Affordable Care ActAmerican Journal of Preventive Medicine, 2019
- Skin Self-examination for Skin Cancer Prevention—ReplyJAMA, 2018
- Patterns and Trends in Cancer Screening in the United StatesPreventing Chronic Disease, 2018
- Update: Providing Quality Family Planning Services — Recommendations from CDC and the U.S. Office of Population Affairs, 2017MMWR. Morbidity and Mortality Weekly Report, 2017
- Screening for Syphilis Infection in Nonpregnant Adults and AdolescentsJAMA, 2016
- Compliance with cervical cancer screening and human papillomavirus testing guidelines among insured young womenAmerican Journal of Obstetrics and Gynecology, 2013
- Recurrent PID, Subsequent STI, and Reproductive Health Outcomes: Findings From the PID Evaluation and Clinical Health (PEACH) StudySexually Transmitted Diseases, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesAnnals of Internal Medicine, 2007
- Effect of pelvic inflammatory disease on fertility.1995